Income Statement Cell Source, Inc.

Stocks

CLCS

US15114L1044

Biotechnology & Medical Research

Market Closed - OTC Markets 09:40:12 2026-10-07 EDT			5-day change	1st Jan Change
0.4988 ^USD	+5.53%		+21.66%	-0.24%

05-14	Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
04-07	Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI

ab6a103612f5b.DNIG8wSSWUWsgLiPZ4yFk_HsYS8lApdRv3-I5DPOM60.VOB0x0XIGijl1IHoSvnVpcKnBENMeOEQ2CbCsHqgcfJihmG-bP0pHdmzyw

Published financial data: CELL SOURCE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Selling General & Admin Expenses, Total	2.64M	2.7M	2.18M	2.6M	1.94M
R&D Expenses	999K	1.32M	2M	1.58M	1.9M
Other Operating Expenses, Total	3.64M	4.02M	4.18M	4.18M	3.84M
Operating Income	-3.64M	-4.02M	-4.18M	-4.18M	-3.84M
Interest Expense, Total	-937K	-1.36M	-992K	-1.05M	-1.09M
Net Interest Expenses	-937K	-1.36M	-992K	-1.05M	-1.09M
Other Non Operating Income (Expenses)	16.98K	-	-	10.9K	398K
EBT, Excl. Unusual Items	-4.56M	-5.38M	-5.17M	-5.22M	-4.53M
Legal Settlements	-	-	-	-143K	-
Other Unusual Items	-1.7K	-93.16K	-	41.92K	17.89K
EBT, Incl. Unusual Items	-4.56M	-5.47M	-5.17M	-5.32M	-4.51M
Earnings From Continuing Operations	-4.56M	-5.47M	-5.17M	-5.32M	-4.51M
Net Income to Company	-4.56M	-5.47M	-5.17M	-5.32M	-4.51M
Net Income - (IS)	-4.56M	-5.47M	-5.17M	-5.32M	-4.51M
Preferred Dividend and Other Adjustments	878K	973K	1.16M	1.23M	1.38M
Net Income to Common Incl Extra Items	-5.44M	-6.45M	-6.33M	-6.55M	-5.89M
Net Income to Common Excl. Extra Items	-5.44M	-6.45M	-6.33M	-6.55M	-5.89M
Per Share Items
Net EPS - Basic	-0.19	-0.19	-0.18	-0.17	-0.14
Basic EPS - Continuing Operations	-0.19	-0.19	-0.18	-0.17	-0.14
Basic Weighted Average Shares Outstanding	29.1M	33.12M	34.84M	37.79M	41.87M
Net EPS - Diluted	-0.19	-0.19	-0.18	-0.17	-0.14
Diluted EPS - Continuing Operations	-0.19	-0.19	-0.18	-0.17	-0.14
Diluted Weighted Average Shares Outstanding	29.1M	33.12M	34.84M	37.79M	41.87M
Normalized Basic EPS	-0.1	-0.1	-0.09	-0.09	-0.07
Normalized Diluted EPS	-0.1	-0.1	-0.09	-0.09	-0.07
Supplemental Items
EBITDA	-	-	-	-	-
EBITA	-3.64M	-4.02M	-4.18M	-4.18M	-3.84M
EBIT	-3.64M	-4.02M	-4.18M	-4.18M	-3.84M
Normalized Net Income	-2.85M	-3.36M	-3.23M	-3.26M	-2.83M
Interest on Long-Term Debt	480K	980K	822K	913K	962K
Supplemental Operating Expense Items
General and Administrative Expenses	2.64M	2.7M	2.18M	2.6M	1.94M
Research And Development Expense From Footnotes	999K	1.32M	2M	1.58M	1.9M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	792K	419K	77.89K	463K	288K
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	792K	419K	77.89K	463K	288K

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Assets
Cash And Equivalents	245K	93.1K	223K	22.2K	74.63K
Total Cash And Short Term Investments	245K	93.1K	223K	22.2K	74.63K
Other Receivables	-	-	-	-	50K
Total Receivables	-	-	-	-	50K
Prepaid Expenses	178K	204K	164K	161K	161K
Other Current Assets, Total	29.65K	16.92K	23K	12.22K	1.12K
Total Current Assets	452K	314K	410K	195K	286K
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	-	-	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Total Assets	452K	314K	410K	195K	286K
Liabilities
Accounts Payable, Total	193K	223K	680K	1.47M	1.89M
Accrued Expenses, Total	3.08M	3.12M	4.22M	4.75M	5.57M
Short-term Borrowings	1.49M	4.66M	7M	8.22M	9.6M
Current Portion of Long-Term Debt	3.42M	1.83M	908K	1.08M	986K
Other Current Liabilities	221K	302K	240K	294K	783K
Total Current Liabilities	8.4M	10.14M	13.04M	15.81M	18.82M
Long-Term Debt	-	-	-	-	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	8.4M	10.14M	13.04M	15.81M	18.82M
Preferred Stock Convertible	1.34K	1.61K	1.84K	1.99K	2.15K
Total Preferred Equity	1.34K	1.61K	1.84K	1.99K	2.15K
Common Stock, Total	32.54K	34.36K	36.08K	39.83K	45.04K
Additional Paid In Capital	17.72M	21.32M	23.67M	26.01M	27.6M
Retained Earnings	-25.71M	-31.18M	-36.35M	-41.67M	-46.18M
Total Common Equity	-7.95M	-9.83M	-12.64M	-15.61M	-18.54M
Total Equity	-7.95M	-9.83M	-12.63M	-15.61M	-18.54M
Total Liabilities And Equity	452K	314K	410K	195K	286K
Supplemental Items
ECS Total Shares Outstanding on Filing Date	32.66M	34.44M	38.16M	41.02M	67.95M
ECS Total Common Shares Outstanding	32.54M	34.36M	36.08M	39.83M	45.04M
Book Value / Share	-0.24	-0.29	-0.35	-0.39	-0.41
Tangible Book Value	-7.95M	-9.83M	-12.64M	-15.61M	-18.54M
Tangible Book Value Per Share	-0.24	-0.29	-0.35	-0.39	-0.41
Total Debt	4.91M	6.5M	7.9M	9.3M	10.58M
Net Debt	4.66M	6.4M	7.68M	9.27M	10.51M
Account Code - Inventory Valuation	3	-	-	3	3
Full Time Employees	1	1	1	1	1

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Net Income	-4.56M	-5.47M	-5.17M	-5.32M	-4.51M
Depreciation & Amortization - CF	-	-	-	-	-
Depreciation & Amortization, Total	-	-	-	-	-
Amortization of Deferred Charges, Total - (CF)	301K	732K	285K	381K	310K
Stock-Based Compensation (CF)	792K	419K	77.89K	445K	288K
Other Operating Activities, Total	269K	242K	102K	-71.08K	-551K
Change In Accounts Payable	57.68K	29.95K	457K	787K	422K
Change in Other Net Operating Assets	366K	671K	1.11M	1.43M	1.36M
Cash from Operations	-2.77M	-3.38M	-3.14M	-2.35M	-2.68M
Short Term Debt Issued, Total	214K	1.5M	2.67M	707K	1.01M
Long-Term Debt Issued, Total	2.55M	2.41M	775K	920K	-
Total Debt Issued	2.76M	3.91M	3.44M	1.63M	1.01M
Short Term Debt Repaid, Total	-354K	-556K	-175K	-279K	-61.05K
Long-Term Debt Repaid, Total	-146K	-125K	-	-	-
Total Debt Repaid	-500K	-681K	-175K	-279K	-61.05K
Issuance of Common Stock	2K	-	-	-	641K
Issuance of Preferred Stock	728K	-	-	800K	1.15M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	2.99M	3.23M	3.27M	2.15M	2.74M
Net Change in Cash	217K	-152K	130K	-200K	52.43K
Supplemental Items
Cash Interest Paid	70.38K	-	-	-	-
Cash Income Tax Paid (Refund)	-	20.77K	19.9K	949	-
Levered Free Cash Flow	-1.55M	-2.18M	-1.34M	-1.04M	-690K
Unlevered Free Cash Flow	-1.27M	-2.06M	-1M	-766K	-320K
Change In Net Working Capital	-215K	-35.28K	-1.53M	-1.39M	-1.79M
Net Debt Issued / Repaid	2.26M	3.23M	3.27M	1.35M	945K

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Profitability
Return on Assets	-801.86	-655.68	-721.27	-864.18	-996.6
Return on Total Capital	74.73	77.63	64.77	47.34	33.88
Return On Equity %	66.62	61.58	46.02	37.68	26.43
Return on Common Equity	79.43	72.52	56.32	46.37	34.48
Short Term Liquidity
Current Ratio	0.05	0.03	0.03	0.01	0.02
Quick Ratio	0.03	0.01	0.02	0	0.01
Operating Cash Flow to Current Liabilities	-0.33	-0.33	-0.24	-0.15	-0.14
Long Term Solvency
Total Debt/Equity	-61.73	-66.12	-62.56	-59.55	-57.09
Total Debt / Total Capital	-161.29	-195.18	-167.12	-147.2	-133.03
LT Debt/Equity	-	-	-	-	-
Long-Term Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	1.86K	3.23K	3.18K	8.1K	6.57K
EBIT / Interest Expense	-3.88	-2.95	-4.21	-3.99	-3.53
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-
Total Debt / (EBITDA - Capex)	-	-	-	-	-
Net Debt / (EBITDA - Capex)	-	-	-	-	-
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-	-	-	-	-
EBITA, 1 Yr. Growth %	-4.39	10.46	3.9	0.18	-8.19
EBIT, 1 Yr. Growth %	-4.39	10.46	3.9	0.18	-8.19
Earnings From Cont. Operations, 1 Yr. Growth %	1.89	20.01	-5.57	2.97	-15.2
Net Income, 1 Yr. Growth %	1.89	20.01	-5.57	2.97	-15.2
Normalized Net Income, 1 Yr. Growth %	7.26	18.01	-3.93	1.02	-13.22
Diluted EPS Before Extra, 1 Yr. Growth %	1.47	4.15	-6.71	-4.53	-18.88
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-	-
Total Assets, 1 Yr. Growth %	294.08	-30.63	30.62	-52.38	46.79
Tangible Book Value, 1 Yr. Growth %	38.4	23.64	28.57	23.57	18.74
Common Equity, 1 Yr. Growth %	38.4	23.64	28.57	23.57	18.74
Cash From Operations, 1 Yr. Growth %	7.24	21.77	-7.1	-25.2	14.32
Levered Free Cash Flow, 1 Yr. Growth %	92.49	49.89	-38.59	-22.11	-39.53
Unlevered Free Cash Flow, 1 Yr. Growth %	101.56	76.25	-51.32	-23.5	-63.09
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-	-	-	-
EBITA, 2 Yr. CAGR %	34.66	2.77	7.13	2.02	-4.1
EBIT, 2 Yr. CAGR %	34.66	2.77	7.13	2.02	-4.1
Earnings From Cont. Operations, 2 Yr. CAGR %	46.75	10.58	6.45	-1.39	-6.55
Net Income, 2 Yr. CAGR %	46.75	10.58	6.45	-1.39	-6.55
Normalized Net Income, 2 Yr. CAGR %	51	12.5	6.47	-1.49	-6.37
Diluted EPS Before Extra, 2 Yr. CAGR %	41.57	2.8	-1.43	-5.63	-12
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-	-	-
Total Assets, 2 Yr. CAGR %	162.21	65.34	-4.81	-21.13	-16.39
Tangible Book Value, 2 Yr. CAGR %	27.09	30.81	26.08	26.04	21.13
Common Equity, 2 Yr. CAGR %	27.09	30.81	26.08	26.04	21.13
Cash From Operations, 2 Yr. CAGR %	17.72	14.28	6.36	-16.64	-7.52
Levered Free Cash Flow, 2 Yr. CAGR %	-7.25	64.29	-4.06	-30.84	-28.15
Unlevered Free Cash Flow, 2 Yr. CAGR %	-14.03	80.89	-7.37	-38.98	-43.5
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-	-	-
EBITA, 3 Yr. CAGR %	16.64	26.06	3.14	4.76	-1.5
EBIT, 3 Yr. CAGR %	16.64	26.06	3.14	4.76	-1.5
Earnings From Cont. Operations, 3 Yr. CAGR %	13.94	37.23	4.91	5.28	-6.23
Net Income, 3 Yr. CAGR %	13.94	37.23	4.91	5.28	-6.23
Normalized Net Income, 3 Yr. CAGR %	25.27	39.09	6.73	4.62	-5.56
Diluted EPS Before Extra, 3 Yr. CAGR %	14.62	27.8	-0.47	-2.48	-10.27
Total Assets, 3 Yr. CAGR %	-5.24	68.32	52.84	-24.44	-2.98
Tangible Book Value, 3 Yr. CAGR %	20.37	25.93	30.06	25.24	23.56
Common Equity, 3 Yr. CAGR %	20.37	25.93	30.06	25.24	23.56
Cash From Operations, 3 Yr. CAGR %	6.64	19.06	6.65	-5.41	-7.38
Levered Free Cash Flow, 3 Yr. CAGR %	-6.31	6.45	18.35	-10.5	-31.81
Unlevered Free Cash Flow, 3 Yr. CAGR %	-13.24	6.26	16.79	-13.09	-46.24
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	9.41	11.63	12.74	15.83	0.18
EBIT, 5 Yr. CAGR %	9.41	11.63	12.74	15.83	0.18
Earnings From Cont. Operations, 5 Yr. CAGR %	12.74	41.41	10.89	20.24	0.17
Net Income, 5 Yr. CAGR %	12.74	41.41	10.89	20.24	0.17
Normalized Net Income, 5 Yr. CAGR %	12.73	40.93	17.38	21.16	1.29
Diluted EPS Before Extra, 5 Yr. CAGR %	13.93	39.42	7.91	13.2	-5.25
Total Assets, 5 Yr. CAGR %	16.06	8.25	-5.07	24.29	20.07
Tangible Book Value, 5 Yr. CAGR %	6.66	9.5	22.62	25.98	26.41
Common Equity, 5 Yr. CAGR %	6.66	9.5	22.62	25.98	26.41
Cash From Operations, 5 Yr. CAGR %	6.76	17.73	6.53	3.24	0.74
Levered Free Cash Flow, 5 Yr. CAGR %	43.08	-2.74	-6.67	-10.41	-3.07
Unlevered Free Cash Flow, 5 Yr. CAGR %	27.91	-6.14	-12.39	-14.88	-12.65